Serratia marcescens keratitis after photorefractive keratectomy.
Rahimi
Firooze
F
Hashemian
Mohammad Naser
MN
Khodabande
Alireza
A
D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003263:Contact Lenses, Hydrophilic / Q000382:microbiology; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D004866:Equipment Contamination; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D009216:Myopia / Q000601:surgery; D018903:Photorefractive Keratectomy; D011183:Postoperative Complications; D016868:Serratia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D012706:Serratia marcescens / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D000583:Amikacin; D002442:Ceftazidime